TAKEDA PHARMACEUTICAL CO LTD 13D and 13G filings for Shattuck Labs, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-14 06:06 am Sale |
2021-12-31 | 13G | Shattuck Labs, Inc. STTK |
TAKEDA PHARMACEUTICAL CO LTD | 2,090,858 4.950% |
-9,454 (-0.45%) |
Filing |
| 2021-01-29 06:06 am Purchase |
2020-12-31 | 13G | Shattuck Labs, Inc. STTK |
TAKEDA PHARMACEUTICAL CO LTD | 2,100,312 5.060% |
2,100,312 (New Position) |
Filing |